Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial

Ítems similars

• A Prospective, Randomized, Double-Blinded, Double-Dummy Pilot Study to Assess the Preemptive Effect of Triple Therapy with Aprepitant, Dexamethasone, and Promethazine versus Ondansetron, Dexamethasone and Promethazine on Reducing the Incidence of Postoperative Nausea and Vomiting Experienced by Patients Undergoing Craniotomy Under General Anesthesia
  per: Bergese, Sergio Daniel, et al.
  Publicat: (2016)
• Triple Therapy with Scopolamine, Ondansetron, and Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Moderate to High-Risk Patients Undergoing Craniotomy Under General Anesthesia: A Pilot Study
  per: Bergese, Sergio D., et al.
  Publicat: (2015)
• The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting
  per: Emami, Hamid, et al.
  Publicat: (2015)
• Effect of the Dexamethasone-Ondansetron Combination Versus Dexamethasone-Aprepitant Combination to Prevent Postoperative Nausea and Vomiting
  per: Bilgen, Sevgi, et al.
  Publicat: (2018)
• Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting
  per: Lim, Chae Seong, et al.
  Publicat: (2013)